A significant difference in the expression of the three cancer testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 was evident and confirmed on protein level by immunohistochemistry in a slightly increased cohort. Here, MAGEA3 is linked to testicular cancer.